Abstract
The effects of two single oral doses of ibopamine (150 and 600 mg) on heart rate, blood pressure, urine flow, sodium, potassium and creatinine excretion were studied in normal volunteers. No significant change was observed in urine flow, sodium, potassium or creatinine excretion at either dose. No significant change was observed in heart rate or blood pressure except that systolic blood pressure was transiently elevated after the 600 mg dose (P less than 0.05).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Casson I. F., Lee M. R., Brownjohn A. M., Parsons F. M., Davison A. M., Will E. J., Clayden A. D. Failure of renal dopamine response to salt loading in chronic renal disease. Br Med J (Clin Res Ed) 1983 Feb 12;286(6364):503–506. doi: 10.1136/bmj.286.6364.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Col J., Mievis E., Reynaert M. Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment. Eur J Clin Pharmacol. 1983;24(3):297–300. doi: 10.1007/BF00610044. [DOI] [PubMed] [Google Scholar]
- Dei Cas L., Bolognesi R., Cucchini F., Fappani A., Riva S., Visioli O. Hemodynamic effects of ibopamine in patients with idiopathic congestive cardiomyopathy. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):249–253. doi: 10.1097/00005344-198303000-00014. [DOI] [PubMed] [Google Scholar]
- Fennell W. H., Taylor A. A., Young J. B., Brandon T. A., Ginos J. Z., Goldberg L. I., Mitchell J. R. Propylbutyldopamine: hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure. Circulation. 1983 Apr;67(4):829–836. doi: 10.1161/01.cir.67.4.829. [DOI] [PubMed] [Google Scholar]
- Goldberg L. I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972 Mar;24(1):1–29. [PubMed] [Google Scholar]
- Goldberg L. I., Kohli J. D., Kotake A. N., Volkman P. H. Characteristics of the vascular dopamine receptor: comparison with other receptors. Fed Proc. 1978 Aug;37(10):2396–2402. [PubMed] [Google Scholar]
- Goldberg L. I., Sonneville P. F., McNay J. L. An investigation of the structural requirements for dopamine-like renal vasodilation: phenylethylamines and apomorphine. J Pharmacol Exp Ther. 1968 Sep;163(1):188–197. [PubMed] [Google Scholar]
- Goldberg L. I., Volkman P. H., Kohli J. D. A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol. 1978;18:57–79. doi: 10.1146/annurev.pa.18.040178.000421. [DOI] [PubMed] [Google Scholar]
- Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
- MCDONALD R. H., Jr, GOLDBERG L. I., MCNAY J. L., TUTTLE E. P., Jr EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW. J Clin Invest. 1964 Jun;43:1116–1124. doi: 10.1172/JCI104996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perkins C. M., Casson I. F., Cope G. F., Lee M. R. Failure of salt to mobilise renal dopamine in essential hypertension. Lancet. 1980 Dec 20;2(8208-8209):1370–1370. doi: 10.1016/S0140-6736(80)92432-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stefoni S., Colì L., Mosconi G., Prandini R. Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report. Br J Clin Pharmacol. 1981 Jan;11(1):69–72. doi: 10.1111/j.1365-2125.1981.tb01104.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stote R. M., Dubb J. W., Familiar R. G., Erb B. B., Alexander F. A new oral renal vasodilator, fenoldopam. Clin Pharmacol Ther. 1983 Sep;34(3):309–315. doi: 10.1038/clpt.1983.173. [DOI] [PubMed] [Google Scholar]